Clinical Trial Update: Dentinal Hypersensitivity Reduction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dentinal hypersensitivity reduction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentinal Hypersensitivity

Snippet

Sponsor: Colgate Palmolive | Conditions: Dentinal Hypersensitivity | Phase 3 | Status: COMPLETED